SCHEMBL6847240

SCHEMBL6847240

CONc1nccc2c(S(=O)(=O)N3CCCNCC3)cccc12

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 6/20 0.67
ROCK1 Q13464 5/20 0.67
PRKCE Q02156 3/20 0.67
PRKCD Q05655 3/20 0.67
PRKD1 Q15139 3/20 0.67
PRKX P51817 2/20 0.67
CYP3A4 P08684 5/20 0.58
KMT2A Q03164 5/20 0.58
CYP2D6 P10635 3/20 0.58
MYLK Q15746 3/20 0.58
NFKB1 P19838 3/20 0.58
CYP1A2 P05177 3/20 0.58
MEN1 O00255 3/20 0.58
TP53 P04637 2/20 0.58
MAPK1 P28482 2/20 0.58
CYP2C9 P11712 1/20 0.58
LMNA P02545 4/20 0.57
TSHR P16473 3/20 0.57
GMNN O75496 2/20 0.57
MAPT P10636 2/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1039708 0.86 ROCK2 (0.71) ROCK2ROCK1PRKCEPRKCDPRKD1
SCHEMBL7049151 0.84 ROCK2 (0.71) ROCK2ROCK1PRKCEPRKCDPRKD1
SCHEMBL13513878 0.83 ROCK2 (0.77) ROCK2ROCK1PRKCEPRKCDPRKD1
Hydroxyfasudil SCHEMBL29473349 0.80 ROCK2 (0.75) ROCK2ROCK1PRKCEPRKCDPRKD1
Hydroxyfasudil SCHEMBL30309462 0.80 ROCK2 (0.75) ROCK2ROCK1PRKCEPRKCDPRKD1
Hydroxyfasudil SCHEMBL1827528 0.80 ROCK2 (0.75) ROCK2ROCK1PRKCEPRKCDPRKD1
SCHEMBL2908958 0.80 ROCK2 (0.75) ROCK2ROCK1PRKCEPRKCDPRKD1
SCHEMBL6845278 0.80 ROCK2 (1.00) ROCK2ROCK1PRKCEPRKCDPRKD1
SCHEMBL7047822 0.80 ROCK2 (0.68) ROCK2ROCK1PRKCEPRKCDPRKD1
Hydroxyfasudil SCHEMBL30198128 0.79 ROCK2 (0.73) ROCK2ROCK1PRKCEPRKCDPRKD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7867999-B1 Hydroxyamino- and amino-substituted pyridine analogs for treating rho kinase-mediated diseases and conditions ALCON RESEARCH, LTD. (US) 2011-01-11 US disclosed